Jaguar Health (JAGX) Shares Outstanding (Diluted Average) (2016 - 2026)

Jaguar Health (JAGX) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $515788.0 in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $515788.0, up 2780.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $515788.0 (up 2780.85% YoY), and the FY2025 annual result was $2.3 million, up 691.9% from the prior year.
• Shares Outstanding (Diluted Average) fell to $515788.0 in Q1 2026 per JAGX's latest filing, from $2.3 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $5.1 million in Q1 2023 and troughed at $15421.0 in Q4 2023.
• A 5-year average of $1.1 million and a median of $778512.0 in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Diluted Average) sank 98.82% in 2023, then surged 2780.85% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.3 million in 2022, then slumped by 98.82% to $15421.0 in 2023, then surged by 1809.95% to $294534.0 in 2024, then soared by 691.9% to $2.3 million in 2025, then slumped by 77.89% to $515788.0 in 2026.
• Business Quant data shows JAGX's Shares Outstanding (Diluted Average) at $515788.0 in Q1 2026, $2.3 million in Q4 2025, and $1.3 million in Q3 2025.